Greenberg Traurig’s Life Sciences & Medical Technology Group Holds Deal-Making Workshop and Networking Reception in San Francisco

Share Article

For the third consecutive year, Greenberg Traurig’s Global Life Sciences & Medical Technology Group hosted two events coincident with the JP Morgan Healthcare Conference in San Francisco.

For the third consecutive year, Greenberg Traurig’s Global Life Sciences & Medical Technology Group hosted two events coincident with the JP Morgan Healthcare Conference in San Francisco.

On Jan. 9, 2017, from 11:30 a.m. – 2 p.m., the Group presented "Insiders' Views of Deal Making," a lively and informative panel discussion that featured seasoned executives from leading life sciences companies. Speakers shared best practices and pitfalls of deals, including M&A, licensing, joint ventures and strategic collaborations. Panelists from the U.S., Europe and China included:

  •     Shaun Grady, VP Strategic Partnering and Business Development, AstraZeneca
  •     Jeremy Sohn, VP, Head of Digital Business Development & Licensing; Global Head of Digital Development, Novartis
  •     Paul Jansen, Associate Vice President Medical Device Development, Sanofi
  •     Lucinda Quan, Executive Director, Transactions, Business Development & Licensing, West Coast Innovation Hub, Merck Research Laboratories
  •     Blake Salisbury, Vice President of Business Development, Innovent Biologics, Inc.

The panel was moderated by the co-chairs of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, David J. Dykeman (Boston shareholder, patent attorney and co-chair of Boston Intellectual Property & Technology Group ) and David C. Peck (Fort Lauderdale shareholder, Corporate & Securities), as well as Fiona Adams (Corporate & Securities shareholder and co-chair of London office).

The program was followed by a private wine tasting and networking reception attended by more than 300 healthcare industry executives and investors.

About Greenberg Traurig’s Life Sciences & Medical Technology Group

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. A single entity worldwide, GTLaw has been recognized for its philanthropic giving, was named the second largest firm in the U.S. by Law360 in 2016, and among the Top 20 on the 2016 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo Martinez
Greenberg Traurig
+1 (212) 801-2131
Email >
Visit website